Scientific Advisory Board

Dr. Umpierrez is a professor of medicine in the division of endocrinology and metabolism at Emory University School of Medicine, Chief of Diabetes and Endocrinology at Grady Memorial Hospital, and Director of the Grady Memorial Hospital Clinical Research Network, Atlanta-CTSA. He heads the Emory Diabetes Council and the nationally-accredited Emory Latino Diabetes Education Program.

Dr. Umpierrez is a national and international leader in the field of hospital management of diabetes and has published more than 300 scientific manuscripts and book chapters, including several landmark papers and guidelines. He has also presented more than 280 research abstracts at national and international scientific meetings.

Additionally, he is the recipient of numerous awards, including the American Association of Clinical Endocrinologists (AACE) Outstanding Service Award for the Promotion of Endocrine Health of an Underserved Population, the American Diabetes Association Outstanding Physician Clinician in Diabetes Award, and the Emory University Department of Medicine Best Grand Rounds Lecture Award.

He serves on the National Board of Directors of the American Diabetes Association and the American Association of Clinical Endocrinologists, and is a member of the Endocrine Society Clinical Guideline Committee and the American Association of Clinical Endocrinologists Diabetes Scientific Council.

Dr. Bode is a diabetologist and head of research at Atlanta Diabetes Associates, an NCQA-accredited physician practice and research organization specializing in the care of people with diabetes and endocrine disorders. He is also a clinical associate professor of medicine at Emory University School of Medicine.

Dr. Bode is considered one of the world’s leading experts in insulin delivery and glucose sensing and is very active in clinical research on new diabetes products, including pharmacological agents, insulins and glucose sensors. He is a member of the JDRF international research team validating the efficacy and safety of real-time continuous glucose monitoring and is a member and former president of the American Diabetes Association Georgia Chapter.

Dr. Bode has written more than 200 articles, abstracts, books and book chapters in the field of diabetes and served as editor of the American Medical Association’s 2004 edition of Medical Management of Type 1 Diabetes. He also serves on the advisory boards of many leading companies in the field of diabetes care and research.

Dr. Bode received a doctorate degree from Emory University School of Medicine, completed an internship and residency at Emory University Affiliated Hospitals and a fellowship in diabetes with Dr. Paul C. Davidson.

Dr. Edelman is a professor of medicine in the division of endocrinology, diabetes and metabolism at University of California San Diego, Director of the Diabetes Care Clinic at the VA San Diego Healthcare System, and founder and Director of Taking Control of Your Diabetes (TCOYD), a national not-for-profit organization with the goal of teaching and motivating patients in diabetes self-care.

Diagnosed with diabetes at the age of 15, Dr. Edelman has become a local and national leader in diabetes treatment, research, education and patient advocacy.

He achieved high honors during his undergraduate studies at University of California Los Angeles and was valedictorian of his class at University of California Davis Medical School. He received internal medicine training at University of California Los Angeles, completed a clinical endocrinology fellowship at the Joslin Diabetes Center and Lahey Clinic in Boston, Massachusetts as well as a research fellowship at University of California San Diego. He is board certified in internal medicine and metabolism, diabetes and endocrinology.

Dr. Edelman has written more than 225 articles and five books and has received numerous awards for teaching and humanitarianism. He has been recognized as a top doctor by San Diego Magazine eight of the last 10 years. He was honored as American Diabetes Association 2009 diabetes educator of the year, received the 2011 Distinction in Endocrinology award from the American Association of Clinical Endocrinologists, has been chosen as University of California San Diego teacher of the year several times, and was recently named amongst the top 1% of endocrinologists in the country by U.S. News & World Report.

Dr. Fleischman is clinical associate professor the department of ophthalmology and visual sciences at Albert Einstein College of Medicine as well as an ophthalmologist and principal at Retina & Laser Consultants LLC.

Since 1984, Dr. Fleischman has lectured and taught surgery around the world through Project ORBIS (the Flying Eye Hospital). He is recognized as an expert in diabetic retinopathy, has authored many papers, and served as an investigator for the landmark Diabetes Control and Complications Trial (DCCT) conducted by the National Institute of Diabetes and Digestive and Kidney Diseases. He is also a member of the Food and Drug Administration’s medical device panel.

Dr. Fleischman holds multiple patents, one pending on a device that will help restore vision to patients with macular degeneration. Of the many surgical devices Dr. Fleischman has invented, the laser endophotocoagulator has become an indispensable tool and a worldwide standard of care for advanced surgical retina cases.

Dr. Fleischman received an undergraduate degree in math and computer engineering and a medical doctorate degree from Columbia University. He worked as a systems analyst/programmer at New York’s NASA Goddard Institute for Space Studies while completing his studies. He received ophthalmology training at Johns Hopkins Wilmer Eye Institute and retina specialty training at the Medical College of Wisconsin.

Dr. Harrison serves as Medical Director of the Diabetes Center at Sentara Virginia Beach General Hospital. He is also an assistant professor of clinical medicine at Eastern Virginia Medical School and senior member of Endocrinology Consultants, an eight-member endocrinology division of Bayview Medical Group in Hampton Roads, Virginia.

Dr. Harrison is a fellow of both the American College of Physicians and American Association of Clinical Endocrinologists, and recipient of the American Diabetes Association Cure, Care, and Commitment Award. He obtained his undergraduate and medical school education at University of Virginia, completed an internal medicine residency at Vanderbilt University and a three-year fellowship in metabolism, nutrition and endocrinology at University of Washington in Seattle.

Dr. Harrison has led myriad initiatives at Sentara Healthcare and played a significant role in the development of diabetes order sets within the health system’s EPIC electronic medical record system. He also participates on the Tier I Glycemic Control Steering Committee.

Dr. Kosiborod is Vice President of Research at Saint Luke’s Health System, Director of Cardiometabolic Research and Co-Director of the Cardio Metabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, and a professor of medicine at the University of Missouri-Kansas City School of Medicine.

He is an internationally recognized expert in the fields of diabetes and cardiovascular disease and is involved in the leadership of numerous clinical trials and multi-center registries. He has authored and co-authored more than 200 peer-reviewed publications, including several scientific statements and position documents.

Dr. Kosiborod received training in clinical epidemiology, health services research and health policy through the Robert Wood Johnson Clinical Scholars Program as well as clinical training in cardiovascular medicine at Yale University School of Medicine. His main research interests include diabetes and glucose control in patients with acute coronary syndromes. He is a recipient of the American Heart Association Career Development Award in Implementation Research for his work addressing knowledge gaps in the relationship between glucose control and outcomes in patients with acute myocardial infraction.

Dr. Kosiborod is actively involved in the work of multiple committees for the American College of Cardiology and American Heart Association, currently chairs the Diabetes Committee of the American Heart Association, and is the training director for the Post-graduate Fellowship in Outcomes Research at Saint Luke’s Mid America Heart Institute. He serves on the editorial boards of several scientific journals, including Journal of the American College of Cardiology.

Dr. Rogers is Chief of the Division of Hospital Medicine, Department of Internal Medicine at University of New Mexico Health Sciences and a professor in the department of internal medicine at University of New Mexico School of Medicine.

He is a Certified Physician Executive through the American College of Physician Leaders, a senior fellow of the Society of Hospital Medicine, and a fellow of the American College of Physicians. He serves on the Society of Hospital Medicine Information Technology Task Force and Public Policy Committee, and is their Glycemic Control Lead Mentor.

Dr. Rogers is board certified in hospital medicine and clinical informatics. He completed his residency at University of New Mexico Health Science Center and earned his medical degree from University Of New Mexico School of Medicine. His research interests are clinical informatics, physician leadership training and quality improvement.

He has been a recipient of several awards, among them: New Mexico Society of Hospital Medicine Hospitalist of the Year, New Mexico Regional ACP Educator of the Year, National Quality Forum and Joint Commission John M. Eisenberg Award, NAPH Safety Net Improving Patient Safety Award for Glycemic Control at University of New Mexico Hospital, and American College of Physicians Top 10 Hospitalists of the Year.

Dr. Rogers co-authored the book, Improving Outcomes with Clinical Decision Support: An Implementer's Guide, Second Edition, which was named 2012 HIMSS Book of the Year in recognition of outstanding practical guidance and/or strategic insight for healthcare information and management systems professionals.

Amy Tenderich is founder and Editor-in-Chief of DiabetesMine, an online information destination for people with diabetes and one of the top health blogs worldwide. As of January 2015, DiabetesMine became part of San Francisco-based Healthline Networks, where Amy now also serves as Editorial Director, Diabetes & Patient Advocacy. Since its inception, DiabetesMine has won numerous awards and was recently named the number one diabetes influencer by ShareCare.com and the American Diabetes Association.

Amy is a well-known public speaker, consultant and advocate for people with diabetes. She is passionate about patient empowerment and has made it her personal mission to spur innovation in diabetes care that originates with the patient. She started DiabetesMine after her own diagnosis with type 1 diabetes in 2003, and in 2006, won the LillyforLife Achievement Award for diabetes journalism from Eli Lilly & Company.

In 2007, Amy penned an open letter to Steve Jobs that went viral, developing into an international crowdsourcing competition called the DiabetesMine Design Challenge. The competition was underwritten by the California HealthCare Foundation and supported by IDEO, a leading design firm with close ties to Stanford University. It culminated in the DiabetesMine Innovation Summit, a unique annual gathering of diabetes stakeholders. Amy was also instrumental in helping conceptualize and launch DiabeticConnect.com, the fastest-growing and most successful social networking site for people with diabetes, with over 800,000 registered members to date.

Amy is co-author (with Dr. Richard Jackson of the Joslin Diabetes Center) of the book, Know Your Numbers, Outlive Your Diabetes, a unique motivational guide to the five key medical tests everyone with diabetes should have and monitor regularly.

Amy has a master's in communication studies from UC Santa Barbara. Prior to her diabetes diagnosis, she had a career in the high-tech industry.